Maynard Um
-
-
-
-
-
-
-
Senti Bio receives FDA advanced therapy designation for leukemia drug
-
-
-
-
-
-
-
Laidlaw Starts Senti Biosciences, Inc. (SNTI) at Buy
-
-
-
-
-
-
-
Senti Biosciences (SNTI) Misses Q4 EPS by 67c
-
-
-
-
-
-
-
Senti Biosciences (SNTI) Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202
-
-
-
415,087 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

